OncoSil Medical
(ASX) OSL
OncoSil Medical Financials at a Glance
Market Cap
$15.81M
Revenue (TTM)
$2.22M
Net Income (TTM)
$25.98M
EPS (TTM)
$-0.95
P/E Ratio
-0.54
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$0.52
Volume
37,135
Open
$0.51
Price
$0.52
Volume
37,135
Open
$0.51
Previous Close
$0.52
Daily Range
$0.50 - $0.52
52-Week Range
$0.46 - $2.09
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$0.52
Volume
37,135
Open
$0.51
Previous Close
$0.52
Daily Range
$0.50 - $0.52
52-Week Range
$0.46 - $2.09
OSL News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout OncoSil Medical
Industry
Life Sciences Tools and Services
Sector
Health CareCEO
Nigel Lange
Website
www.oncosil.com.auHeadquarters
Macquarie Park, NSW 2060, AU
OSL Financials
Key Financial Metrics (TTM)
Gross Margin
-3%
Operating Margin
-12%
Net Income Margin
-10%
Return on Equity
-208%
Return on Capital
-4%
Return on Assets
-2%
Earnings Yield
-1.85%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$15.81M
Shares Outstanding
30.70M
Volume
37.13K
Avg. Volume
67.30K
Financials (TTM)
Gross Profit
$1.08M
Operating Income
$15.49M
EBITDA
$15.06M
Operating Cash Flow
$12.06M
Capital Expenditure
$14.96K
Free Cash Flow
$12.08M
Cash & ST Invst.
$5.11M
Total Debt
$69.92K
OncoSil Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$782.89K
+790.1%
Gross Profit
$3.22M
-0.0%
Gross Margin
-4.12%
N/A
Market Cap
$15.81M
N/A
Market Cap/Employee
$7.90M
N/A
Employees
2
N/A
Net Income
$4.53M
+24.8%
EBITDA
$6.94M
-7.0%
Quarterly Fundamentals
Net Cash
$2.81M
-41.2%
Accounts Receivable
$3.27M
+455.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$42.47K
-38.2%
Return on Assets
-1.81%
N/A
Return on Invested Capital
-4.00%
N/A
Free Cash Flow
$6.96M
-61.7%
Operating Cash Flow
$6.96M
-61.6%